Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Thrombosis and Haemostasis
|
August 28, 2002
Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation
Ilene C Weitz, Valerie K Israel, James R Waisman, et al.
Thrombosis Research
|
October 27, 2009
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism
David A Manly, Jianguo Wang, Sam L Glover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2009
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy
Jeffrey I Zwicker, Howard A Liebman, Donna Neuberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2006
Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance
Casey L O'Connell, William D Boswell, Vinay Duddalwar, et al.
British Journal of Haematology
|
July 9, 2013
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study
Howard A Liebman, Mansoor N Saleh, James B Bussel, et al.
Haematologica
|
August 13, 2016
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia
Howard A Liebman, Mansoor N Saleh, James B Bussel, et al.
Thrombosis Research
|
May 1, 2012
Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation
Ilene C Weitz, Pedram Razavi, Leanne Rochanda, et al.
Gynecologic Oncology
|
December 25, 2012
Predictive model of venous thromboembolism in endometrial cancer
Koji Matsuo, Annie A Yessaian, Yvonne G Lin, et al.
BJU International
|
August 2, 2008
Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy
Scott T Tagawa, Tanya B Dorff, Leanne Rochanda, et al.
Blood
|
June 8, 2007
A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP)
Michael D Tarantino, James B Bussel, Douglas B Cines, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Thrombosis and Haemostasis
|
August 28, 2002
Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation
Ilene C Weitz, Valerie K Israel, James R Waisman, et al.
Thrombosis Research
|
October 27, 2009
Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism
David A Manly, Jianguo Wang, Sam L Glover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2009
Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy
Jeffrey I Zwicker, Howard A Liebman, Donna Neuberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2006
Unsuspected pulmonary emboli in cancer patients: clinical correlates and relevance
Casey L O'Connell, William D Boswell, Vinay Duddalwar, et al.
British Journal of Haematology
|
July 9, 2013
Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study
Howard A Liebman, Mansoor N Saleh, James B Bussel, et al.
Haematologica
|
August 13, 2016
Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia
Howard A Liebman, Mansoor N Saleh, James B Bussel, et al.
Thrombosis Research
|
May 1, 2012
Eculizumab therapy results in rapid and sustained decreases in markers of thrombin generation and inflammation in patients with PNH independent of its effects on hemolysis and microparticle formation
Ilene C Weitz, Pedram Razavi, Leanne Rochanda, et al.
Gynecologic Oncology
|
December 25, 2012
Predictive model of venous thromboembolism in endometrial cancer
Koji Matsuo, Annie A Yessaian, Yvonne G Lin, et al.
BJU International
|
August 2, 2008
Subclinical haemostatic activation and current surgeon volume predict bleeding with open radical retropubic prostatectomy
Scott T Tagawa, Tanya B Dorff, Leanne Rochanda, et al.
Blood
|
June 8, 2007
A closer look at intravascular hemolysis (IVH) following intravenous anti-D for immune thrombocytopenic purpura (ITP)
Michael D Tarantino, James B Bussel, Douglas B Cines, et al.
Page
of 7